JOSD2 and non-small cell lung carcinoma: In hope of identifying critical DUB(s) as new therapeutic target for NSCLC, we performed a global profiling of 97 DUBs and discovered that JOSD2 played an important role in promoting cell proliferation of NSCLC both in vitro and in vivo.